Sperm damage and spermatogenesis impairment after treatment with paroxetine: an androgenic disruption?

Vol. 1, 2019. - 116792
Pôster
Favorite this paper
How to cite this paper?
Abstract

The impact of the antidepressant paroxetine (a selective serotonin reuptake inhibitor) on spermatogenesis, sperm parameters and steroidogenesis was evaluated in adult rats. Animals received 10mg/Kg b.w. of paroxetine or distilled water orally for 35 days. Semen was collected from epididymis cauda for analysis of morphology, motility, vitality, and mitochondrial activity (RCA). In testes, the histopathology, germ cell death (TUNEL) and 17β-HSD7 immunoexpression (steroidogenesis) were evaluated. Serum and intratesticular testosterone was measured. In treated-animals, sperm motility and RCA reduced, while the frequency of abnormal and dead spermatozoa increased significantly. Testosterone levels decreased and weak 17β-HSD7 immunoexpression was observed. Seminiferous tubules with epithelial disorganization, detached germ cells in the lumen, and TUNEL-positive Sertoli and germ cells were found. Sertoli cells number and frequency of tubules at androgen-dependent stages also reduced. The changes in sperm parameters and seminiferous epithelium may be related, at least in part, to the androgenic failure caused by paroxetine.

Institutions
  • 1 Federal University of São Paulo, Department of Morphology and Genetics, São Paulo - Brazil
  • 2 Universidade Paulista - UNIP, Araraquara - Brazil
  • 3 Department of Morphology, Dental School of São Paulo State University, Araraquara - Brazil
Track
  • Pharmacology and Physiology
Keywords
antidepressant
sperm
testosterone